Optogenetic Therapy for Restoring Aspects of Visual Function
A 10-participant study reported gains on some visual tasks, with results varying and normal sight not restored.
TL;DR
- A New England Journal of Medicine study examined optogenetic therapy paired with specialized goggles in 10 people with advanced retinitis pigmentosa.
- The University of Basel said several participants improved on some visual-function tests, while outcomes varied and the treatment did not restore high-resolution vision.
- The results are early clinical evidence from a small study and do not establish the treatment’s broader effectiveness or long-term outcomes.
The New England Journal of Medicine published results from a study of optogenetic therapy for advanced retinitis pigmentosa. The approach used gene therapy to make surviving retinal cells respond to light, paired with goggles that convert camera images into light signals. [NEJM; University of Basel.] [1] [2]
The University of Basel reported that the study involved 10 participants. Seven showed greater light sensitivity in the treated eye with the goggles, six reached the study’s predefined threshold for a clinically meaningful change, and four of eight who completed object-detection tests improved consistently across several tasks. Results varied between participants. [University of Basel; NEJM.] [1] [2]
The university said the study’s primary aim was safety, that most eye-related adverse events were mild or moderate, and that the therapy did not restore high-resolution vision. The small study does not establish long-term effectiveness. [NEJM; University of Basel.] [1] [2]
Why it matters
The findings provide a clinical signal for a mutation-independent approach that uses surviving retinal cells, but the study’s small size and variable task-level results keep the evidence preliminary. The next research question is whether larger studies can establish durable, useful visual function.
Editor's note
Reported as early clinical evidence. This story is not medical advice and does not support treatment decisions.